Colorectal Cancer Detection Act

Senate Bill 892 - Colorectal Cancer Detection Act: Overview, Status, and Impact

Hozzl · 2023-12-15T16:06:43Z

Explore the details of Senate Bill 892 Colorectal Cancer Detection Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

12/15/2023, 4:06 PM

Congressional Summary of S 892

Colorectal Cancer Detection Act

This bill provides for Medicare coverage and payment, subject to specified frequency limits, of certain colorectal cancer screening blood-based tests.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 892

Bill S 892 is currently in the status of Bill Introduced since March 21, 2023. Bill S 892 was introduced during Congress 118 and was introduced to the Senate on March 21, 2023. Bill S 892's most recent activity was Read twice and referred to the Committee on Finance. as of March 21, 2023

Bipartisan Support of Bill S 892

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill S 892

Primary Policy Focus

Health

Potential Impact Areas

- Blood and blood diseases

- Cancer

- Digestive and metabolic diseases

- Health promotion and preventive care

- Medical tests and diagnostic methods

- Medicare

Alternate Title(s) of Bill S 892

Colorectal Cancer Detection Act

A bill to amend title XVIII of the Social Security Act to provide coverage under the Medicare program for FDA-approved qualifying colorectal cancer screening blood-based tests, to increase participation in colorectal cancer screening in under-screened communities of color, to offset the COVID-19 pandemic driven declines in colorectal cancer screening, and for other purposes.